注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
江苏亚虹医药科技股份有限公司是一家主要从事药物研发的中国公司。该公司专注于泌尿生殖系统肿瘤及其它重大疾病领域的创新药物。该公司正在研发的产品管线包括APL-1202、APL-1501、APL-1706、APL-1702、ASN-1764、ASN-1780、APL-1901、APL-1401和ASN-1733等。该公司尚处于研发阶段。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Hanzhong Li | - | - | Member of Clinical Advisory Committee |
Zhisong He | - | - | Member of Clinical Advisory Committee |
Dingwei Ye | - | - | Chairman of Clinical Advisory Committee |
Fangjian Zhou | - | - | Member of Clinical Advisory Committee |
Bin Huang | 57 | 2020 | Independent Director |
Joseph Liao | - | 2024 | Member of the Advisory Board |
Xianxian Li | 35 | 2020 | Supervisor |
Zeng Liu | 40 | 2020 | Director |
Chengfeng Zhuang | 61 | 2019 | Deputy GM & Director |
Zhihua Yu | 57 | 2017 | Director |
Badrinath Konety | - | 2022 | Member of Scientific Advisory Board |
Yinglu Guo | - | - | Honorary Chairman of Clinical Advisory Committee |
Bing Hui Zhang | 61 | 2020 | Independent Director |
Kan Chen | 42 | 2020 | Director |
Yi Zhong | 51 | 2020 | Chairman of the Supervisory Board |
Yangwen Qin | 56 | 2020 | Independent Director |
Mingyuan Yang | 41 | 2020 | Financial , Director & Board Secretary |
Neal D. Shore | - | 2024 | Member of the Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核